Ethyl 2,4-Dimethylpyrrole-3-Carboxylate Bulk Price 2026: Market Analysis & Procurement Guide
- 2026 Price Forecast: Stable pricing expected due to optimized synthesis routes and raw material availability.
- Technical Specs: Target purity ≥98.0% (GC) with strict control over melting point (76°C) and impurities.
- Procurement Advantage: Significant volume discounts available for kilogram to metric ton scale orders.
The pharmaceutical intermediate market is rapidly evolving, with specific demand surging for heterocyclic compounds used in oncology drug development. Among these, Ethyl 2,4-dimethylpyrrole-3-carboxylate (CAS: 2199-51-1) remains a critical building block. As we approach 2026, procurement managers and process chemists must understand the factors influencing the bulk price of this key material. This analysis provides a technical and commercial overview for securing supply chains effectively.
Global Market Pricing Trends for Kinase Inhibitor Precursors
The cost structure for pyrrole derivatives is heavily influenced by the availability of precursor amines and keto-esters required for the synthesis route. Historically, price volatility has been linked to fluctuations in petrochemical feedstocks. However, market indicators for 2026 suggest a stabilization in costs due to improved manufacturing efficiencies.
As a vital kinase inhibitor precursor, this compound is essential in the production of multi-kinase inhibitors used to treat various cancers. The demand trajectory is upward, driven by the expansion of generic pharmaceutical portfolios. Buyers should anticipate that while spot prices for gram-scale quantities remain high, the bulk price for industrial quantities is becoming more competitive. Manufacturers who have vertical integration into raw material synthesis can offer better margin protection against market swings.
Technical Specifications and Industrial Purity
For process chemistry applications, meeting standard physical constants is non-negotiable. The material typically presents as a white to yellow crystalline powder. Strict quality control parameters must be enforced to ensure downstream reaction yields are not compromised by impurities.
| Parameter | Specification | Test Method |
|---|---|---|
| Chemical Name | 2,4-Dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester | GC-MS |
| CAS Number | 2199-51-1 | N/A |
| Molecular Weight | 167.21 g/mol | Calculation |
| Purity | ≥98.0% | GC (Area %) |
| Melting Point | 74°C - 78°C | DSC / Capillary |
| Boiling Point | 162°C (approx.) | Distillation |
| Appearance | White to Yellow Crystalline Powder | Visual |
Maintaining industrial purity is crucial. Impurities such as unreacted starting materials or regio-isomers can affect the crystallization profile of the final active pharmaceutical ingredient (API). Therefore, sourcing from a global manufacturer with robust quality assurance systems is essential. Every batch should be accompanied by a comprehensive COA (Certificate of Analysis) detailing impurity profiles and residual solvent data.
Volume Discount Structures for Wholesale Procurement
Pricing models for chemical intermediates differ significantly between laboratory reagents and industrial bulk supplies. Laboratory grades often carry a premium due to packaging and handling costs. In contrast, wholesale procurement focuses on cost-per-kilogram efficiency.
Standard tiered pricing structures usually apply:
- Development Scale (1kg - 10kg): Higher unit cost to cover setup and QC validation.
- Pilot Scale (10kg - 100kg): Moderate discounts applied as batch sizes increase.
- Commercial Scale (100kg+): Maximum pricing efficiency, often negotiated via annual supply agreements.
When evaluating suppliers for Ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate, technical consistency is paramount alongside cost. A lower unit price is negligible if the batch-to-batch variability causes production delays. NINGBO INNO PHARMCHEM CO.,LTD. specializes in bridging this gap, offering scalable solutions that maintain strict technical specifications regardless of order volume.
Applications in Pharmaceutical Synthesis
This pyrrole carboxylate derivative is most notably recognized as a Sunitinib intermediate. Sunitinib malate is a potent inhibitor of receptor tyrosine kinases, used in the treatment of renal cell carcinoma and gastrointestinal stromal tumors. The efficiency of the coupling reactions involving this ester directly impacts the overall yield of the final drug substance.
Beyond oncology, the compound finds utility in custom synthesis projects targeting neurological disorders and agrochemical developments. The electron-rich nature of the pyrrole ring allows for diverse functionalization, making it a versatile scaffold for medicinal chemistry teams exploring new chemical entities.
Logistics and Incoterms for Bulk Chemical Shipping
Secure logistics are the backbone of international chemical trade. For hazardous or sensitive organic intermediates, proper packaging and documentation are critical. Bulk orders are typically shipped in fiber drums or lined bags, ensuring protection against moisture and light degradation.
Common Incoterms for this commodity include:
- FOB (Free on Board): Buyer assumes responsibility once goods are loaded onto the vessel.
- CIF (Cost, Insurance, and Freight): Seller covers costs and insurance to the destination port.
- DDP (Delivered Duty Paid): Seller handles all risks and costs until delivery to the buyer's premises.
Lead times vary based on production schedules. Standard inventory items may ship within 3-5 days, while made-to-order batches require 2-4 weeks for synthesis and QC release. Import regulations must be considered, including TSCA compliance for shipments entering specific regions. Documentation such as the Safety Data Sheets (SDS) and Certificates of Origin (COO) must be accurate to prevent customs delays.
Conclusion: Securing Supply for 2026
The outlook for Ethyl 2,4-Dimethylpyrrole-3-Carboxylate remains positive, with stable pricing anticipated for the coming year. However, the key to successful procurement lies in partnering with a manufacturer that prioritizes quality assurance and technical support. Process chemists require more than just a commodity; they need a reliable partner who understands the nuances of synthesis and scale-up.
For organizations seeking a dependable supply chain, NINGBO INNO PHARMCHEM CO.,LTD. stands out as a premier provider. By combining advanced manufacturing capabilities with rigorous quality control, they ensure that every shipment meets the exacting standards required for modern pharmaceutical production. Planning ahead for 2026 requirements now will secure both pricing advantages and production continuity.